Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Amivantamab and lazertinib in treatment-naive EGFR-mutated advanced non-small-cell lung cancer (NSCLC): Long-term follow-up and ctDNA results from CHRYSALIS.
- Authors
- Lee, SH[Lee, Se-Hoon]; Cho, BC[Cho, Byoung Chul]; Han, JY[Han, Ji-Youn]; Cho, EK[Cho, Eun Kyung]; Lee, JS[Lee, Jong-Seok]; Lee, KH[Lee, Ki Hyeong]; Curtin, JC[Curtin, Joshua C.]; Gao, G[Gao, Grace]; Xie, J[Xie, John]; Schnepp, RW[Schnepp, Robert W.]; Bauml, JM[Bauml, Joshua Michael]; Knoblauch, RE[Knoblauch, Roland E.]; Thayu, M[Thayu, Meena]; Kim, DW[Kim, Dong-Wan]
- Issue Date
- 1-Jun-2023
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.41, no.16
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 41
- Number
- 16
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.